about
N-Acylethanolamines in seeds. Quantification Of molecular species and their degradation upon imbibitionInitial insight into the function of the lysosomal 66.3 kDa protein from mouse by means of X-ray crystallographyX-ray Crystallographic Analysis of α-Ketoheterocycle Inhibitors Bound to a Humanized Variant of Fatty Acid Amide HydrolaseFluoride-Mediated Capture of a Noncovalent Bound State of a Reversible Covalent Enzyme Inhibitor: X-ray Crystallographic Analysis of an Exceptionally Potent α-Ketoheterocycle Inhibitor of Fatty Acid Amide HydrolaseReversible Competitive α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Containing Additional Conformational Constraints in the Acyl Side Chain: Orally Active, Long-Acting AnalgesicsRational Design of Fatty Acid Amide Hydrolase Inhibitors That Act by Covalently Bonding to Two Active Site ResiduesWhat we know and do not know about the cannabinoid receptor 2 (CB2)Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cellsN-Acylphosphatidylethanolamine accumulation in potato cells upon energy shortage caused by anoxia or respiratory inhibitorsCannabinoid-receptor-independent cell signalling by N-acylethanolaminesFormation of a new class of oxylipins from N-acyl(ethanol)amines by the lipoxygenase pathwayBiosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase DThe evolution and comparative neurobiology of endocannabinoid signallingStress regulates endocannabinoid-CB1 receptor signaling.A novel class of oxylipins, sn1-O-(12-oxophytodienoyl)-sn2-O-(hexadecatrienoyl)-monogalactosyl Diglyceride, from Arabidopsis thaliana.Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death.Identification of endocannabinoids and related compounds in human fat cells.α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.Endocannabinoid system acts as a regulator of immune homeostasis in the gut.Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets.Comparative biology of the endocannabinoid system possible role in the immune response.A liquid chromatography-tandem mass spectrometry method for measurement of N-modified phosphatidylethanolamines.Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.Lipid profiling reveals tissue-specific differences for ethanolamide lipids in mice lacking fatty acid amide hydrolase.A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development.Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA).Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways.The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neuronsFunctional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family.Impact of oxygen stress and energy availability on membrane stability of plant cellsPhosphatidylserine in the brain: metabolism and function.Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats.'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide.Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation.Generation of N-acylphosphatidylethanolamine by members of the phospholipase A/acyltransferase (PLA/AT) family.Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide.The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics
P2860
Q24555159-A1BEEFA8-9E8D-4FF7-ABCE-40043C66DDA4Q27657154-E8E827C1-B071-4949-A266-321110D319FAQ27658264-14AF891B-6C00-4FBB-BAEC-0F85728B7129Q27667078-B65DDD22-836C-440A-BE17-C3BD92FA0582Q27667312-AF1BDC7F-A19E-4CCB-93F8-843F37C13A09Q27677344-35707377-4732-4C3B-A4D1-9FC234621F86Q27686851-F89E34AA-BE01-42F0-B303-3D9E3816249CQ28345246-9306B5A2-9143-43A6-9AC6-A925C016C1B5Q28351436-226F73D7-CDFD-4663-A9F6-3CEA345C0123Q28363293-A61CC984-6743-40B9-88E2-B214EDCE8694Q28373850-40D0E279-1E91-4223-9DE7-B42B6590AA7FQ28581971-0E9263AA-4D85-4C25-BF87-4BECF19703CDQ28714675-81F8AC63-0437-4147-82C4-F73AC77581EAQ30402136-2E10885D-F819-4980-8AA0-BF4DE600DBA9Q30661608-1F48A408-999E-4BFE-A082-FC0FDEACE9EFQ31807488-7851BDA3-E569-44B1-99A0-0EF761B3A017Q33437059-DF43C656-4FA7-48CA-86C8-06A43BD40067Q33644120-E1996E29-AD35-44B2-A631-16FA77A4D6C2Q33719329-3D6F7D72-E991-4C08-B361-EEBC6B336833Q33946795-15F79269-9049-42DF-8BAC-C71646395F12Q33994487-4AD38EAA-2C1B-483B-9752-4CE5FFE78C3AQ34069221-B12711D2-3154-4988-B02E-7DDFCCE7765FQ34083248-4575DF83-0E1D-48D6-BAE9-5D9EA9183B10Q34150144-B7D4867B-A265-4900-AEE4-7E53C7D8875AQ34205553-F590D9CE-A21C-47F9-87FA-87F1E69A0039Q34292125-121D5091-65FB-4EAB-9D1E-3F1B11E6424BQ34328745-BD2025D6-3CC7-4A48-9C32-291AF6373ACFQ34380089-5019E1A8-E2AE-463C-B1A4-7E1AFB312432Q34500986-B0736E86-FAAF-4EEA-9500-40F305269A39Q34556302-E247BC7B-898C-41E5-A9E3-DA852192B1D2Q34647336-C6443157-CA7E-4360-8B8E-93CD807148ACQ34772868-895AB133-F6CC-4E4A-9464-1A5D5143FE3DQ34807355-36B253A1-9CB4-4C3B-873C-4EBE2749B6E9Q35684044-ABCA9402-9B1C-4C1C-8378-D56ACDB74EB0Q36057140-6D76C2D6-6F94-4EEC-B26C-B094C5DD4C6BQ36111506-667C23FA-4029-430A-A951-08660D601C43Q36234744-0DB198BD-4A7F-4579-94F4-EE7A05F37C6BQ36463167-CB2AC531-A721-4C9B-AE47-2CFE9733A05DQ36655240-42D48CDC-5D5C-44D7-A2A0-D0F9344B999DQ36803312-8FECB1CB-72E6-4280-A06A-3F504E6819BA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
N-acylated glycerophospholipids and their derivatives.
@en
N-acylated glycerophospholipids and their derivatives.
@nl
type
label
N-acylated glycerophospholipids and their derivatives.
@en
N-acylated glycerophospholipids and their derivatives.
@nl
prefLabel
N-acylated glycerophospholipids and their derivatives.
@en
N-acylated glycerophospholipids and their derivatives.
@nl
P2093
P1476
N-acylated glycerophospholipids and their derivatives.
@en
P2093
P356
10.1016/0163-7827(90)90004-5
P577
1990-01-01T00:00:00Z